{"id":2985,"date":"2017-09-28T16:34:03","date_gmt":"2017-09-28T15:34:03","guid":{"rendered":"https:\/\/bestpractice.bmj.com\/?page_id=2985"},"modified":"2021-11-30T16:48:27","modified_gmt":"2021-11-30T16:48:27","slug":"about-us","status":"publish","type":"page","link":"https:\/\/bestpractice.bmj.com\/info\/us\/about-us\/","title":{"rendered":"About us"},"content":{"rendered":"

BMJ Best Practice is a<\/strong> generalist point of care tool particularly useful for medical residents, multidisciplinary teams, specialists working outside of their specialty, and General Internal Medicine doctors. It is uniquely structured around the patient consultation with advice on symptom evaluation, test ordering, and treatment approach.<\/h3>
\r\nSince the launch of BMJ Best Practice in 2009, we have supported thousands of customers and users worldwide to improve clinical decision making and ultimately patient outcomes.
\r\n
\r\nThis clinical decision support tool is particularly useful for medical students, junior doctors, multidisciplinary team members (such as nurses and pharmacists), specialists working outside of their specialty, and primary care practitioners.<\/span>
\r\n
\r\nBMJ Best Practice includes<\/span> 1000+ evidence-based condition and symptom topics across 32 clinical specialties <\/a><\/b>which provide the user with <\/span>guidance throughout the full patient journey, from determining diagnosis and treatment approach to follow up support.<\/span>
\r\n
\r\nThe clinical information focuses on the most commonly presented conditions, as well as those that are clinically significant or relevant to global health such as COVID-19<\/a>, Ebola<\/a> and Zika virus<\/a>. <\/span>
\r\n

Our team of experts<\/strong><\/h2>
\r\nOur in-house evidence team<\/a> collaborates with over 1,600 international expert authors and over 2,500 peer reviewers to ensure that users always have the latest evidence-based information that is practical for the clinical setting.<\/span>
\r\n

BMJ Best Practice also offers <\/strong><\/h2>
\r\n